Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Search

News & Events

Recruitment for AdDIT now complete

Young people diagnosed with Type 1 Diabetes are at risk of complications from their diabetes including kidney, heart, eye and vascular disease.

News & Events

WA teenager with type 1 diabetes on a mission to become a pro-cyclist

A wiry tall teenager, who was struggling somewhat with his blood glucose control, he turned up on his trusty bike, and we had something in common to talk about.

News & Events

Low Carbohydrate Diets

Carbohydrate restriction is used by some individuals with type 1 diabetes to reduce glucose excursions after eating a meal.

News & Events

Diabete$ Re$earch in Au$tralia

It may surprise you to know that the Australian government has invested almost $300 million dollars since 2000 towards research and clinical trials for diabetes

News & Events

Our country kids are doing well

Research has shown that no matter where our patients reside in WA, whether it be remote or metropolitan based, the ongoing management of diabetes is the same.

News & Events

Best practice in diabetes care

Last month, our Centre's co-Director Liz Davis, attended the National Association of Diabetes Centre's (NADC) Symposium in Sydney.

News & Events

Diabetes Camp changes for 2016-2017

You may have heard we're moving to our new home at Perth Children's Hospital later this year, sadly this means we've had to cancel our camps.

News & Events

Smartphone donations

The Diabetes Research Team is requesting donations of old iPhones for a new study investigating the effect of real time CGM on every day diabetes management.

Research

Clinical Outcomes with MiniMedTM 780G Advanced Hybrid Closed-Loop Therapy in 2- to 6-Year-Old Children with Type 1 Diabetes

Advanced hybrid closed-loop (AHCL) therapy with the Medtronic MiniMedâ„¢ 780G system improves glycemia; however, the clinical outcomes in younger children remain less established. This pilot study aimed to explore the continuous glucose monitoring (CGM) metrics in very young children on AHCL. Children between 2 and 7 years of age and on insulin pump therapy were recruited.

Research

Hybrid Closed-Loop Versus Manual Insulin Delivery in Adults With Type 1 Diabetes: A Post Hoc Analysis Using the Glycemia Risk Index

Glycemia risk index (GRI) is a novel composite metric assessing overall glycemic risk, accounting for both hypoglycemia and hyperglycemia and weighted toward extremes. Data assessing GRI as an outcome measure in closed-loop studies and its relation with conventional key continuous glucose monitoring (CGM) metrics are limited.